Results 111 to 120 of about 35,745 (266)

The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial. [PDF]

open access: yesVaccine, 2023
Chowdhury F   +20 more
europepmc   +1 more source

AVibrio choleraeghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin [PDF]

open access: bronze, 2008
E. Ekong   +8 more
openalex   +1 more source

Increased risk for malaria in chronically malnourished children under 5 years of age in rural Gambia.

open access: yes, 2002
Malaria and malnutrition cause high morbidity and mortality in rural sub-Saharan Africa. To explore the relationship between nutritional status and malaria, a cohort of Gambian children under 5 years of age was followed weekly during one malaria season ...
Deen, JL, von Seidlein, L, Walraven, GEL
core   +1 more source

Immune Responses to O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 Ogawa in Adult Bangladeshi Recipients of an Oral Killed Cholera Vaccine and Comparison to Responses in Patients with Cholera [PDF]

open access: bronze, 2014
Taher Uddin   +23 more
openalex   +1 more source

Cholera in Sub-Saharan Africa: Unveiling neglected drivers and pathways to elimination.

open access: yesPLoS Neglected Tropical Diseases
Cholera is a virulent infectious disease caused by the Gram-negative, comma-shaped bacteria Vibrio cholerae, after ingesting contaminated food and/or water. If left untreated, it can kill within 5 days.
Beenzu Siamalube   +4 more
doaj   +1 more source

Re-emergence of Cholera Vaccine [PDF]

open access: bronze, 1997
Stephen A. Berger, Itzhak Shapiro
openalex   +1 more source

The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi.

open access: yes, 2005
BACKGROUND: The proportion of cases of tuberculosis due to recent infection can be estimated in long-term population-based studies using molecular techniques.
Crampin, Amelia C   +8 more
core   +1 more source

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines. [PDF]

open access: yesVaccines (Basel), 2021
Albutti A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy